Changeflow GovPing Healthcare ONCOASSIST Trademark Published for Opposition
Routine Notice Added Final

ONCOASSIST Trademark Published for Opposition

Favicon for changeflow.com USPTO Trademarks - Medical Services (Class 044)
Published
Detected
Email

Summary

The USPTO published trademark application TM99736989 for ONCOASSIST on April 1, 2026, opening a 30-day opposition period. The application, filed March 31, 2026, covers Class 44 medical services including cancer research promotion, medical education advertising, and health information services.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO published the ONCOASSIST trademark application (TM99736989) for opposition on April 1, 2026. The trademark covers services including promoting cancer research awareness, advertising medical education content, providing cancer diagnosis and treatment information, and medical information services via the Internet. Third parties have a standard 30-day window to file an opposition with the TTAB if they believe the mark creates likelihood of confusion with existing trademarks in the same class.

Third parties who believe they would be damaged by registration of ONCOASSIST should monitor the opposition deadline and consider filing a Notice of Opposition with the Trademark Trial and Appeal Board. Healthcare providers, pharmaceutical companies, and medical device manufacturers operating in the cancer services space should review the application to assess potential conflict with their own marks.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

ONCOASSIST

Published for Opposition TM99736989 Kind: published Apr 01, 2026

Abstract

Promoting public awareness in the field of cancer research; Promoting awareness of cancer, cancer treatments, and cancer diagnosis; Promoting the goods and services of others by providing ads in software programs; Consumer survey services; Promotional marketing services; Promoting pharmaceuticals for others; Advertising services; Advertising services in the field of cancer; Advertising, marketing and promotion services in the field of the medical education content of others; Providing health information in the field of cancer; Medical information services provided via the Internet; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Medical information; Providing medical information; Providing information about medical research in the field of cancer; Providing information about medical research

Filing Date

2026-03-31

View original document →

Named provisions

Class 044 - Medical Services

Get daily alerts for USPTO Trademarks - Medical Services (Class 044)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99736989

Who this affects

Applies to
Healthcare providers Medical device makers Pharmaceutical companies
Industry sector
6211 Healthcare Providers
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Consumer Protection

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!